Agenda

Return

C. 47

To:	Board of Supervisors
From:	William Walker, M.D., Health Services Director
Date:	October 20, 2015

Contra

Costa

County

Subject:

Amendment #26-583-20 with Specialty Laboratories, Inc. (dba Quest Diagnostics Nichols Institute of Valencia)

APPROVE	OTHER
RECOMMENDATION OF CNTY ADMINISTRATOR	RECOMMENDATION OF BOARD COMMITTEE

Action of Board On: 10/20/2015

APPROVED AS RECOMMENDED

OTHER

Clerks Notes:

VOTE OF SUPERVISORS

AYE:

John Gioia, District I Supervisor
Candace Andersen, District II Supervisor
Mary N. Piepho, District III Supervisor
Karen Mitchoff, District IV Supervisor
Federal D. Glover, District V Supervisor

Contact:	Anna Roth, 925-370-5101
cc:	K Cyr N Rios

I hereby certify that this is a true and correct copy of an action taken and entered on the minutes of the Board of Supervisors on the date shown.
ATTESTED: October 20, 2015
David Twa,

BY:	, Deputy

RECOMMENDATION(S):

Approve and authorize the Health Services Director, or his designee, to execute, on behalf of the County, Contract Amendment Agreement #26-583-20 with Specialty Laboratories, Inc. (dba Quest Diagnostics Nichols Institute of Valencia), a corporation, effective August 1, 2015, (to amend Contract #26-583-18) to increase the payment limit by $600,000, from $950,000 to a new payment limit of $1,550,000, with no change in the original term of January 1, 2015 through December 31, 2015.

FISCAL IMPACT:

This amendment is funded 100% Hospital Enterprise Fund I. (No rate increase)

BACKGROUND:

On January 6, 2015, the Board of Supervisors approved Contract #26-583-18, with Specialty Laboratories, Inc. (dba Quest Diagnostics Nichols Institute of Valencia) for the provision of outside specialized clinical laboratory services at Contra Costa Regional Medical Center and Contra Costa Health Centers (CCRMC), for the period from January 1, 2015 through December 31, 2015. At the time of negotiations, the payment limit was based on target levels of utilization. However, the volume of specialized testing has been much higher than originally anticipated due to the increased use of a new cancer screening test, the BRACA test. Approval of Contract Amendment Agreement #26-583-20 will allow the Contractor to continue to provide additional outside clinical laboratory services at CCRMC through December 31, 2015.

CONSEQUENCE OF NEGATIVE ACTION:

If this amendment is not approved, the Contractor will not be paid for additional specialized testing services provided to CCRMC patients during the contract period.

CHILDREN'S IMPACT STATEMENT:

Not applicable.